Profusa, Inc.

Profusa, Inc. (PFSA) is a medical technology company focused on implantable, tissue-integrating biosensors designed for continuous real-time monitoring of biological signals including oxygen and glucose levels. The company is publicly traded and filed its annual Form 10-K with the Securities and Exchange Commission on April 15, 2026, covering its most recent fiscal year of operations and financial results. Profusa operates in the life sciences and digital health sector, with its platform targeting clinical monitoring and connected health applications through minimally invasive, injectable sensor technology. To access full filing data, deal history, and SPAC analytics on Profusa and thousands of other companies, sign up for SpacDesk today.